Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications Francis John Tierney has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11850232

COMPOUNDS AND THEIR USE AS BACE INHIBITORS

IPC classification:
A61K 31/4184, A61K 31/4188, A61K 31/4439, A61K 31/506, A61P 25/28, C07D 235/02, C07D 401/04, C07D 401/12, C07D 403/12, C07D 405/12, C07D 491/107, C07D 491/20
Applicant:
AstraZeneca AB
Agent:
Francis John Tierney, AstraZeneca PLC
Agent:
Multiple attorneys, Ropes & Gray International LLP
Agent:
Jeremy Suhail Rashid, White & Case LLP
Status:
PATENT GRANTED
EP13159532

Ethanamine compounds and methods of using the same

IPC classification:
A61K 31/4402, A61P 25/24, C07D 213/38
Applicant:
AstraZeneca AB
Agent:
Francis John Tierney, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12806636

GABR-A2 DIAGNOSTIC

IPC classification:
C12Q 1/68
Applicant:
AstraZeneca AB
Agent:
Francis John Tierney, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11829686

CRYSTALLINE NALOXOL-PEG CONJUGATE

IPC classification:
A61K 47/48, A61P 39/00, C07D 489/04
Applicant:
AstraZeneca AB
Agent:
Jones Day
Agent:
Boult Wade Tennant Ltd
Agent:
Francis John Tierney, AstraZeneca PLC
Status:
PATENT GRANTED

Please Sign in to use this feature